XML 50 R39.htm IDEA: XBRL DOCUMENT v3.5.0.2
SEGMENT INFORMATION (Tables)
 6 Months Ended
Jun. 30, 2016
Segment Reporting [Abstract]  
Schedule of segment revenues and profit
Segment revenues and profit for the three-month and six-month periods ended June 30, 2016 and 2015 were as follows:
 
Three Months Ended
June 30,
 
Six Months Ended
June 30,
 
2016
 
2015
 
2016
 
2015
(restated)
Revenues:
 
 
 
 
 
 
 
Developed Markets(1)
$
1,923.5

 
$
2,237.6

 
$
3,853.4

 
$
3,981.2

Emerging Markets(2)
496.7

 
494.8

 
938.4

 
921.3

Total revenues
2,420.2

 
2,732.4

 
4,791.8

 
4,902.5

 
 
 
 
 
 
 
 
Segment profit:
 
 
 
 
 
 
 
Developed Markets(3)
107.6

 
678.5

 
367.2

 
1,346.2

Emerging Markets(4)
48.4

 
78.3

 
66.7

 
132.9

Total segment profit
156.0

 
756.8

 
433.9

 
1,479.1

 
 
 
 
 
 
 
 
Corporate(5)
(77.0
)
 
(61.5
)
 
(223.4
)
 
(130.7
)
Restructuring, integration and other costs
(19.5
)
 
(143.4
)
 
(57.5
)
 
(198.4
)
In-process research and development impairments and other charges
(17.4
)
 
(12.3
)
 
(17.9
)
 
(12.3
)
Acquisition-related costs
—

 
(9.5
)
 
(1.8
)
 
(23.4
)
Acquisition-related contingent consideration
(6.9
)
 
(11.7
)
 
(9.3
)
 
(18.8
)
Other income (expense)
45.3

 
(176.9
)
 
22.7

 
(183.0
)
Operating income
80.5

 
341.5

 
146.7

 
912.5

Interest income
2.1

 
0.9

 
3.0

 
1.8

Interest expense
(472.5
)
 
(412.7
)
 
(899.1
)
 
(710.5
)
Loss on extinguishment of debt
—

 
—

 
—

 
(20.0
)
Foreign exchange and other
13.1

 
5.6

 
6.9

 
(65.5
)
(Loss) income before (recovery of) provision for income taxes
$
(376.8
)
 
$
(64.7
)
 
$
(742.5
)
 
$
118.3

____________________________________
(1)
Developed Markets segment revenues reflect incremental product sales revenue in the three-month and six-month periods ended June 30, 2016 from 2015 acquisitions of $24 million and $537 million, respectively, in the aggregate, primarily from the Salix Acquisition and the acquisition of certain assets of Dendreon.
(2)
Emerging Markets segment revenues reflect incremental product sales revenue in the three-month and six-month periods ended June 30, 2016 from 2015 acquisitions of $57 million and $115 million, respectively, in the aggregate, primarily from the Amoun Acquisition.
(3)
Developed Markets segment profit in the three-month and six-month periods ended June 30, 2016 reflects the impact of acquisition accounting adjustments related to the fair value adjustments to inventory and identifiable intangible assets of $808 million and $1.45 billion, respectively, in the aggregate, primarily from the Salix Acquisition, compared with $555 million and $870 million in the corresponding periods of 2015.
(4)
Emerging Markets segment profit in the three-month and six-month periods ended June 30, 2016 reflects the impact of acquisition accounting adjustments related to the fair value adjustments to inventory and identifiable intangible assets of $87 million and $173 million, respectively, in the aggregate, compared with $76 million and $151 million in the corresponding periods of 2015.
(5)
Corporate reflects non-restructuring-related share-based compensation expense of $20 million and $70 million in the three-month and six-month periods ended June 30, 2016, respectively, compared with $14 million and $38 million in the corresponding periods of 2015. The expense in the three-month and six-month periods ended June 30, 2016, included a charge relating to the acceleration of vesting of the performance-based RSUs held by the Company's former Chief Executive Officer. See Note 12 for additional information.
Schedule of total assets by segment
Total assets by segment as of June 30, 2016 and December 31, 2015 were as follows:
 
As of
June 30,
2016
 
As of
December 31,
2015
Assets:
 
 
 
Developed Markets
$
39,897.8

 
$
41,182.7

Emerging Markets
6,693.6

 
6,897.4

 
46,591.4

 
48,080.1

Corporate
1,070.8

 
884.4

Total assets
$
47,662.2

 
$
48,964.5